Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Endometrial Neoplasms 20Anorexia 11Cachexia 9Neoplasms 8Breast Neoplasms 8Endometrial Hyperplasia 7Weight Loss 3Recurrence 2Overweight 2Obesity 2Lung Neoplasms 2Head and Neck Neoplasms 2Body Weight Changes 2Body Weight 2Vomiting 1Turcot syndrome 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Prosthesis Failure 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Nutrition Disorders 1Neoplasms, Second Primary 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Mesothelioma, Malignant 1Menorrhagia 1

Interventions

Exercise 3Early Intervention, Educational 3Counseling 3Psychiatric Rehabilitation 2Megestrol Acetate 2Cyproheptadine 2Yoga 1Watchful Waiting 1Vegetables 1Standard of Care 1Radiotherapy 1Professional Autonomy 1Oxandrolone 1Observation 1Nutritional Status 1Nutrition Therapy 1Motivational Interviewing 1Methods 1Magnetic Resonance Spectroscopy 1Immunoenzyme Techniques 1Fruit 1Exercise Therapy 1Diet, Fat-Restricted 1Diet 1Creatine 1Control Groups 1Calcium 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Body Weight Changes × Megestrol Acetate × Clear all
NCT00070148 2021-09-09

Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer

Wake Forest University Health Sciences

Phase 3 Completed
155 enrolled

Body Weight Changes

NCT01200602 2015-11-25

Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy

Mayo Clinic

Phase 2 Terminated
1 enrolled

Anorexia, Body Weight Changes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡